Organometallics
Article
Synthesis of [1-Mes-3-{2-(PCy2)phenyl}imidazolidin-2-ylium][BF4]
(10). This was prepared similarly to 11 (see below) from 5 (318 mg,
0.706 mmol), with a reaction time of 15 min. The product was
obtained as a white powder in 94% yield (365 mg, 0.666 mmol), which
was determined to be approximately 80% pure by integration of 31P
NMR resonances. 1H NMR (500 MHz, CDCl3): δ 7.84 (ddd, J = 8.0,
3.9, 1.2 Hz, 1H, 3-Ph), 7.80 (d, J = 2.7 Hz, 1H, NCHN+), 7.59 (dt, J =
7.6, 1.7 Hz, 1H, 6-Ph), 7.54 (td, J = 7.7, 1.4 Hz, 1H, 4-Ph), 7.47 (td, J
= 7.5, 1.2 Hz, 1H, 5-Ph), 6.99 (d, J = 0.4 Hz, 2H, m-Mes), 4.69 (dd, J
= 12.3, 9.3 Hz, 2H, NCH2), 4.44 (dd, J = 12.2, 9.4 Hz, 2H, NCH2),
2.44 (s, 6H, m-CH3 Mes), 2.32 (s, 3H, p-CH3 Mes), 1.87−1.65 (ov m,
10H, Cy), 1.46−1.30 (ov m, 4H, Cy), 1.18−1.06 (ov m, 6H, Cy),
0.98−0.89 (ov m, 2H, Cy). 13C{1H} NMR (126 MHz, CDCl3): δ
157.6 (d, J = 7.4 Hz, NCHN+), 141.7 (d, J = 23.2 Hz), 140.8 (s), 135.7
(s), 134.2 (d, J = 3.8 Hz, 6-Ph), 131.9 (d, J = 23.3 Hz), 131.6 (s, 4-Ph),
130.2 (s), 130.1 (s, m-Mes), 129.7 (s, 5-Ph), 127.3 (d, J = 3.0 Hz, 3-
Ph), 54.3 (d, J = 6.2 Hz, NCH2), 51.6 (s, NCH2), 34.2 (d, J = 11.3 Hz,
CH Cy), 30.8 (d, J = 17.2 Hz, CH2 Cy), 29.4 (d, J = 7.3 Hz, CH2 Cy),
26.9 (d, J = 13.0 Hz, CH2 Cy), 26.8 (d, J = 8.2 Hz, CH2 Cy), 26.1 (s,
CH2 Cy), 21.1 (s, p-CH3 Mes), 18.0 (d, J = 4.0 Hz Hz, p-CH3 Mes).
31P{1H} NMR (202 MHz, CDCl3): δ −16.5 (s).
Synthesis of [1-Mes-3-{2-(PAd2)phenyl}imidazolidin-2-ylium][BF4]
(11). In air, compound 6 (1.55 g, 2.79 mmol) and NH4BF4 (351 mg,
3.35 mmol) were combined in a 4 dram vial. A 10 mL portion of
CH(OEt)3 was added, and the open vial was heated to 110 °C with
vigorous stirring for 30 min. The resulting white precipitate was
collected by filtration and washed copiously with diethyl ether (5 × 5
mL). The product was taken up in CH2Cl2 and filtered through a
sintered glass frit. Solvent was removed from the resulting clear
solution, providing the product as a beige powder in 98% yield (1.79 g,
2.74 mmol). 1H NMR (500 MHz, CDCl3): δ 7.89−7.86 (m, 2H, 3-Ph
+ 6-Ph), 7.82 (d, J = 3.2 Hz, 1H, NCHN+), 7.58 (td, J = 7.7, 1.1 Hz,
1H, 4-Ph), 7.46 (td, J = 7.6, 1.2 Hz, 1H, 5-Ph), 7.00 (s, 2H, m-Mes),
4.72 (dd, J = 12.3, 9.3 Hz, 2H, NCH2), 4.43 (dd, J = 12.2, 9.4 Hz, 2H,
NCH2), 2.48 (s, 6H, o-CH3 Mes), 2.32 (s, 3H, p-CH3 Mes), 1.92−1.90
(m, 12H, Ad), 1.83−1.81 (m, 6H, Ad), 1.66 (m, 12H, Ad). 13C{1H}
NMR (126 MHz, CDCl3): δ 157.2 (d, J = 7.0 Hz), 142.4 (d, J = 25.2
Hz), 140.8 (s), 137.4 (d, J = 2.0 Hz, 6-Ph), 135.9 (s), 131.9 (s, 4-Ph),
130.7 (d, J = 28.5 Hz), 130.4 (s), 130.2 (s, m-Mes), 128.7 (s, 5-Ph),
127.7 (d, J = 3.1 Hz, 3-Ph), 54.3 (d, J = 5.8 Hz, NCH2), 51.6 (s,
NCH2), 42.2 (d, J = 11.4 Hz, CH2 Ad), 37.6 (d, J = 21.3 Hz,
quaternary Ad), 36.7 (s, CH2 Ad), 28.7 (d, J = 9.0 Hz, CH Ad), 21.2
(s, p-CH3 Mes), 18.1 (s, o-CH3 Mes). 31P{1H} NMR (202 MHz,
CDCl3): δ 14.2 (s).
CDCl3): δ 7.54 (t, J = 7.9 Hz, 1H, 5-Ph), 7.49 (t, 3JHH = 3JPH = 7.5 Hz,
1H, 3-Ph), 7.09−7.03 (m, 3H, o+m-Dipp), 6.96 (td, J = 7.5, 3.5 Hz,
1H, 4-Ph), 6.86 (dd, J = 8.5, 3.4 Hz, 1H, 6-Ph), 6.19 (d, J = 4.0 Hz,
1H, PCH+), 4.35−4.29 (m, 1H, OCH2), 4.17−4.07 (m, 1H, OCH2),
3.92−3.77 (m, 2H, NCH2), 3.27 (sp, J = 6.8 Hz, 2H, CH(CH3)2),
3.18−3.06 (m, 2H, NCH2), 2.51−2.49 (m, 3H, Ad), 2.22−2.17 (m,
6H, Ad), 2.11 (s, 10H, Ad), 1.91−1.83 (m, 3H, Ad), 1.79 (br s, 6H,
Ad), 1.76−1.67 (m, 3H, Ad), 1.30 (t, J = 7.0 Hz, 3H, OCH2CH3), 1.20
(d, J = 6.8 Hz, 6H, CH(CH3)2), 1.17 (d, J = 6.8 Hz, 6H, CH(CH3)2).
13C{1H} NMR (126 MHz, CDCl3): δ 155.0 (d, J = 8.3 Hz), 143.1 (s),
142.6 (s), 136.9 (d, J = 1.2 Hz, 5-Ph), 131.7 (d, J = 4.4 Hz, 3-Ph),
124.2 (s, p-Dipp), 123.6 (s, m-Dipp), 119.6 (d, J = 10.1 Hz, 4-Ph),
110.7 (d, J = 6.5 Hz, 6-Ph), 97.6 (d, J = 71.3 Hz), 90.7 (d, J = 63.7 Hz,
PCH+), 69.4 (d, J = 4.3 Hz, OCH2), 49.9 (s, NCH2), 49.0 (d, J = 6.2
Hz, NCH2), 43.4 (d, J = 24.7 Hz, quaternary Ad), 41.0 (d, J = 26.2 Hz,
quaternary Ad), 37.2 (d, J = 2.6 Hz, CH2 Ad), 36.9 (d, J = 2.5 Hz, CH2
Ad), 35.9 (s, CH2 Ad), 35.4 (s, CH2 Ad), 27.9 (d, J = 9.7 Hz, CH Ad),
27.7 (d, J = 9.4 Hz, CH Ad), 27.6 (s, CH(CH3)2), 24.5 (s,
CH(CH3)2), 24.4 (s, CH(CH3)2), 15.6 (s, OCH2CH3). 31P{1H} NMR
(202 MHz, CDCl3): δ 32.3 (s).
Synthesis of 2-Bromo-N-phenylbenzenamine (14). This was
prepared similarly to 1 from bromoiodobenzene (566 mg, 2.0
mmol) and aniline (186 mg, 2 mmol). After a reaction time of 15
min at 110 °C, the reaction mixture was cooled to ambient
temperature, filtered through a bed of silica, and washed down with
DCM (10 mL). Removal of volatiles afforded the title compound as a
light yellow liquid in 97% yield (482 mg, 1.94 mmol). NMR data
closely match previously reported values for this compound.30 1H
NMR (500 MHz, CDCl3): δ 7.53 (dd, J = 8.0, 1.5 Hz, 1H), 7.35−7.31
(m, 2H), 7.26 (dd, J = 8.2, 1.5 Hz, 1H), 7.19−7.15 (m, 3H), 7.05 (tt, J
= 7.4, 1.1 Hz, 1H), 6.75 (ddd, J = 8.0, 7.2, 1.6 Hz, 1H), 6.10 (br s,
1H).
Synthesis of 2-Dicyclohexylphosphino-N-phenylbenzenamine
(15). This was prepared similarly to 4 from 14 (248 mg, 1.0 mmol)
and dicyclohexylphosphine (198 mg, 1.0 mmol), with a reaction time
of only 30 min at 110 °C. Purification by flash chromatography (20/1
hexanes/EtOAc) gave the product as a light yellow solid in 91% yield
(333 mg, 0.91 mmol). 1H NMR (500 MHz, CDCl3): δ 7.32 (ddd, J =
7.6, 2.8, 1.5 Hz, 1H, 6-Ph), 7.30−7.25 (m, 3H, 3-Ph + m-NPh), 7.21
(td, J = 7.7, 1.4 Hz, 1H, 4-Ph), 7.16 (br d, J = 11.1 Hz, 1H, NH), 7.13
(dd, J = 8.5, 1.0 Hz, 2H, o-NPh), 6.94 (tt, J = 7.3, 1.1 Hz, 1H, p-NPh),
6.87 (td, J = 7.4, 1.2 Hz, 1H, 5-Ph), 1.93 (tq, J = 11.8, 2.9 Hz, 2H, Cy),
1.88−1.85 (m, 2H, Cy), 1.77−1.73 (m, 2H, Cy), 1.71−1.61 (m, 6H,
Cy), 1.34−1.03 (m, 10H, Cy). 13C{1H} NMR (126 MHz, CDCl3): δ
149.2 (d, J = 18.3 Hz), 143.2 (s), 133.5 (s, 6-Ph), 129.6 (s, 4-Ph),
129.3 (s, m-NPh), 121.4 (s, p-NPh), 120.5 (d, J = 12.8 Hz), 119.6 (s,
5-Ph), 119.1 (s, o-NPh), 115.7 (s, 3-Ph), 32.9 (d, J = 9.4 Hz, Cy CH),
30.5 (d, J = 16.2 Hz, Cy CH2), 28.8 (d, J = 6.8 Hz, Cy CH2), 27.4 (d, J
= 12.5 Hz, Cy CH2), 27.1 (d, J = 7.9 Hz, Cy CH2), 26.5 (s, Cy CH2).
31P{1H} NMR (202 MHz, CDCl3): δ −24.4 (s). HRMS (ESI/[M +
Synthesis of Phosphonium Salt 12. This was prepared similarly to
11 from 7, giving the phosphonium salt compound in 91% yield (243
1
mg, 0.91 mmol). H NMR (500 MHz, CDCl3): δ 7.75 (t, J = 7.3 Hz,
1H, 5-Ph), 7.70 (t, J = 7.9 Hz, 1H, 4-Ph), 7.42 (dd, J = 8.8, 7.3 Hz, 2H,
m-NPh), 7.29 (dd, J = 8.3, 3.4 Hz, 1H, 3-Ph), 7.25 (td, J = 7.6, 2.9 Hz,
1H, 6-Ph), 7.10−7.04 (ov m, 3H, o+p-NPh), 6.61 (d, J = 24.2 Hz, 1H,
PCH+), 3.97 (t, J = 6.8 Hz, 2H, NCH2), 3.76 (td, J = 6.8, 1.6 Hz, 2H,,
NCH2), 2.21−2.18 (m, 6H, Ad), 2.05−1.98 (m, 12H, Ad), 1.74−1.68
(m, 12H, Ad). 13C{1H} NMR (126 MHz, CDCl3): δ 155.4 (d, J = 15.6
Hz), 144.1 (s), 136.3 (s, 4-Ph), 132.6 (s, 5-Ph), 130.1 (s, m-NPh),
123.6 (d, J = 8.1 Hz, 6-Ph), 122.9 (s, p-NPh), 117.6 (d, J = 5.7 Hz, 3-
Ph), 117.3 (s, o-NPh), 88.6 (br s, PCH+), 51.9 (s, NCH2), 51.3 (d, J =
3.5 Hz, NCH2), 42.7 (d, J = 14.9 Hz, quaternary Ad), 38.2 (s, CH2
Ad), 35.7 (s, CH2 Ad), 27.9 (d, J = 9.1 Hz, CH Ad). 31P{1H} NMR
(202 MHz, CDCl3): δ 36.2 (s).
H]+): calcd for C24H32NP 366.2345, found 366.2339.
Synthesis of Phosphonium Salt 16. In air, compound 15 (258 mg,
0.706 mmol) was combined with NH4BF4 (89 mg, 0.85 mmol), 3 mL
of CH(OEt)3, and a stir bar in a 4 dram vial. The open vial was heated
to 110 °C with vigorous stirring for 20 min, at which point an orange
oil was observed to have separated. Upon cooling, 5 mL of diethyl
ether was added to encourage complete precipitation. The supernatant
was decanted, and the oil was washed with diethyl ether (3 × 2 mL).
The resulting solid material was taken up in CH2Cl2 and filtered.
Evaporation of the solvent afforded 267 mg of the product as a light
yellow powder. The collected supernatant and washings were left to
stand for 24 h, resulting in crystallization of a further 64 mg of product,
giving a combined yield of 92% (331 mg, 0.650 mmol). 1H NMR (500
Synthesis of Phosphonium Salt 13. In air, diamine compound 8
(50 mg, 0.084 mmol) was combined with NH4BF4 (10 mg, 0.095
mmol), 1 mL of CH(OEt)3, and a stir bar in a 1 dram vial. The open
vial was heated to 80 °C with vigorous stirring for 10 min. The
resulting white precipitate was separated by decanting and then
washed with diethyl ether (3 × 2 mL). The powder was taken up in
CH2Cl2 and filtered through a sintered-glass frit, and the volatiles were
removed to provide 13 mg of the title compound. The collected
supernatant and washings were left to stand for 24 h, which resulted in
the crystallization of an additional 16 mg of material, giving a
3
3
MHz, CDCl3): δ 7.53 (t, JHH = JPH = 7.9 Hz, 1H, 3-Ph), 7.50−7.44
(ov m, 3H, 5-Ph + m-NPh), 7.41−7.35 (m, 3H, o+p-NPh), 6.99 (td, J
= 7.5, 3.4 Hz, 1H, 4-Ph), 6.64 (dd, J = 8.5, 3.4 Hz, 1H, 6-Ph), 6.17 (d, J
= 1.9 Hz, 1H, PCH+), 3.88 (dq, J = 9.3, 7.1 Hz, 1H, OCH2CH3), 3.48
(dq, J = 9.1, 7.1 Hz, 1H, OCH2CH3), 3.33−3.25 (m, 1H, Cy), 2.92
(qt, J = 13.3, 2.9 Hz, 1H, Cy), 2.30−2.27 (m, 1H, Cy), 2.16−2.05 (m,
3H, Cy), 1.98−1.94 (m, 2H, Cy), 1.86−1.66 (m, 7H, Cy), 1.55 (qt, J =
1
combined yield of 47% (29 mg, 0.039 mmol). H NMR (500 MHz,
J
dx.doi.org/10.1021/om400684n | Organometallics XXXX, XXX, XXX−XXX